Patent US4173526A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4173526A Expired / Lapsed US ⏱️ 0.0 years remaining

Chlor-alkali cell diaphragm and its treatment

Assignee: EIDP Inc
•
Filing: 1978-11-21
•
Granted: 1979-11-06
•
Expires: 1998-11-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Magnesium compounds are added to chlor-alkali cell asbestos diaphragms, either initially or after some use, to improve electrical operating characteristics.

Inventors

  • 👤 James C. Fang

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 05:38
CPC Classifications
C; C25; C25B; C25B13/00; C25B13/04; C25B1/00; C25B1/01; C25B1/34; C25B1/46; C25B13/05; C25B13/06; C25B13/07

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 55 words
A diaphragm for a chlor-alkali cell comprising asbestos and at least one magnesium compound selected from magnesium oxide, hydroxide, carbonate, oxyhalide and hydroxyhalide (wherein the halide is at least one of fluorine and chlorine), the magnesium compound being present in an amount of about 5-50% by weight based on the asbestos plus the magnesium compound.
Claim 2
Dependent Claim 55 words
A diaphragm for a chlor-alkali cell comprising asbestos and at least one magnesium compound selected from magnesium oxide, hydroxide, carbonate, oxyhalide and hydroxyhalide (wherein the halide is at least one of fluorine and chlorine), the magnesium compound being present in an amount of about 5-50% by weight based on the asbestos plus the magnesium compound.
Claim 3
Dependent Claim 27 words
The diaphragm of claim 1 wherein the magnesium compound is present in an amount of about 35-45% by weight based on the asbestos plus the mangesium compound.
Claim 4
Dependent Claim 24 words
The diaphragm of claim 1 wherein the magnesium compound is magnesium oxide having an average particle size about in the range of 1.0-2.0 μm.
Claim 5
Dependent Claim 11 words
The diaphragm of claim 1 which also contains a fluoropoylmer binder.
Claim 6
Dependent Claim 48 words
A process for treating a chlor-alkali cell diaphragm which comprises passing through the diaphragm a slurry containing a magnesium compound selected from magnesium oxide, hydroxide, carbonate, oxyhalide and hydroxyhalide (wherein the halide is at least one of fluorine and chlorine), and depositing such magnesium compound within the diaphragm.
Claim 7
Dependent Claim 48 words
A process for treating a chlor-alkali cell diaphragm which comprises passing through the diaphragm a slurry containing a magnesium compound selected from magnesium oxide, hydroxide, carbonate, oxyhalide and hydroxyhalide (wherein the halide is at least one of fluorine and chlorine), and depositing such magnesium compound within the diaphragm.
Claim 8
Dependent Claim 20 words
The process of claim 5 wherein, before said treating, the diaphragm has been subjected to electrolysis in a chlor-alkali cell.
Claim 9
Dependent Claim 29 words
The process of claim 6 wherein the electrolysis has been sufficient to increase the operating voltage of the diaphragm and the treatment decreases the operating voltage for subsequent electrolysis.
Claim 10
Dependent Claim 14 words
The diaphragm of claim 4 wherein the fluoropolymer binder is a fluorocarbon polymer binder.

References Cited (Backward Citations)

US3238056A Cited
US3989615A Cited
US3849243A Cited
US4003818A Cited
US4093533A Cited
US4081350A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-11-05 1983-05-07 1983-11-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-11-05 1987-05-07 1987-11-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-11-05 1991-05-07 1991-11-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag